drugset / Press release

Material Information - The Company Announces Filing of New Drug Submission of BESREMi (Ropeginterferon alfa-2b) for PV in Canada

2025-07-18 · PharmaEssentia · original pharmaessentia.com ↗

Ropeginterferon alfa-2b · regulatory alfa-2b

Download Material Information - The Company Announces Filing of New Drug Submission of BESREMi (Ropeginterferon alfa-2b) for PV in Canada Previous Next

The release as fetched from its publisher. pharmaessentia.com ↗